27
Participants
Start Date
August 6, 2024
Primary Completion Date
August 29, 2024
Study Completion Date
December 30, 2024
Anvitra Gastric Suspension
Anvitra Gastric Suspension is provided as a liquid oral preparation, designed with a pleasant flavor to ensure compliance in patients. The intervention involves administering 1 packet (15 ml) per dose three times daily, taken orally 30 minutes after meals, for a duration of 14 days. The supplement is intended to alleviate symptoms of GERD (heartburn, regurgitation, and dyspepsia). Anvitra Gastric Suspension has been widely used in clinical and community settings, with a favorable safety profile and reported effectiveness in GERD treament.
Center for Clinical Trial and Bioequivalence Study, Haiphong
Center for Clinical Trial and Bioequivalence Study, Haiphong University of Medicine and Pharmacy, Haiphong
Haiphong University of Medicine and Pharmacy
OTHER